Clinical trials sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Phase breakdown

Conditions studied

Recruiting trials led by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

• Effects of Treatments on Atopic Dermatitis
  NCT01631617 · Phase: Phase 2 · Ages: 2 Years to 50 Years · Sex: All (male and female) · 1 location
• Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
  NCT05567198 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: Female · 1 location
• Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
  NCT03510442 · Phase: Not specified · Ages: 1 Day to 100 Years · Sex: All (male and female) · 1 location
• Study of Systemic Lupus Erythematosus
  NCT00001372 · Phase: Not specified · Ages: 3 Years to 120 Years · Sex: All (male and female) · 1 location
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
  NCT05440422 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) recruiting for?

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.